Barclays’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-29,510
| Closed | -$129K | – | 4315 |
|
|
2025
Q1 | $129K | Sell |
29,510
-10,377
| -26% | -$45.4K | ﹤0.01% | 3579 |
|
|
2024
Q4 | $186K | Buy |
39,887
+4,055
| +11% | +$18.9K | ﹤0.01% | 3554 |
|
|
2024
Q3 | $252K | Buy |
35,832
+19,965
| +126% | +$140K | ﹤0.01% | 3370 |
|
|
2024
Q2 | $109K | Sell |
15,867
-37,391
| -70% | -$257K | ﹤0.01% | 3332 |
|
|
2024
Q1 | $754K | Buy |
+53,258
| New | +$754K | ﹤0.01% | 2597 |
|
|
2022
Q2 | – | Sell |
-1,410
| Closed | -$18K | – | 4678 |
|
|
2022
Q1 | $18K | Sell |
1,410
-9,135
| -87% | -$117K | ﹤0.01% | 4352 |
|
|
2021
Q4 | $185K | Buy |
10,545
+5,614
| +114% | +$98.5K | ﹤0.01% | 2854 |
|
|
2021
Q3 | $107K | Sell |
4,931
-968
| -16% | -$21K | ﹤0.01% | 3198 |
|
|
2021
Q2 | $207K | Sell |
5,899
-12,026
| -67% | -$422K | ﹤0.01% | 2877 |
|
|
2021
Q1 | $1.77M | Sell |
17,925
-11,553
| -39% | -$1.14M | ﹤0.01% | 1958 |
|
|
2020
Q4 | $3.19M | Sell |
29,478
-10,125
| -26% | -$1.1M | ﹤0.01% | 1277 |
|
|
2020
Q3 | $4.08M | Buy |
39,603
+11,321
| +40% | +$1.17M | ﹤0.01% | 1069 |
|
|
2020
Q2 | $5.91M | Buy |
28,282
+1,414
| +5% | +$295K | ﹤0.01% | 845 |
|
|
2020
Q1 | $2.63M | Sell |
26,868
-19,456
| -42% | -$1.9M | ﹤0.01% | 1193 |
|
|
2019
Q4 | $5.34M | Buy |
46,324
+41,814
| +927% | +$4.82M | ﹤0.01% | 1179 |
|
|
2019
Q3 | $246K | Sell |
4,510
-1,478
| -25% | -$80.6K | ﹤0.01% | 2970 |
|
|
2019
Q2 | $711K | Buy |
5,988
+1,079
| +22% | +$128K | ﹤0.01% | 2546 |
|
|
2019
Q1 | $258K | Buy |
4,909
+3,123
| +175% | +$164K | ﹤0.01% | 2918 |
|
|
2018
Q4 | $56K | Sell |
1,786
-5,128
| -74% | -$161K | ﹤0.01% | 3142 |
|
|
2018
Q3 | $418K | Buy |
6,914
+4,698
| +212% | +$284K | ﹤0.01% | 2729 |
|
|
2018
Q2 | $117K | Sell |
2,216
-7,372
| -77% | -$389K | ﹤0.01% | 2999 |
|
|
2018
Q1 | $556K | Buy |
9,588
+6,143
| +178% | +$356K | ﹤0.01% | 2218 |
|
|
2017
Q4 | $120K | Buy |
3,445
+3,000
| +674% | +$104K | ﹤0.01% | 2916 |
|
|
2017
Q3 | $16K | Sell |
445
-10,953
| -96% | -$394K | ﹤0.01% | 3276 |
|
|
2017
Q2 | $285K | Buy |
11,398
+10,068
| +757% | +$252K | ﹤0.01% | 2240 |
|
|
2017
Q1 | $35K | Buy |
1,330
+352
| +36% | +$9.26K | ﹤0.01% | 3211 |
|
|
2016
Q4 | $28K | Buy |
+978
| New | +$28K | ﹤0.01% | 2994 |
|
|
2016
Q3 | – | Sell |
-50
| Closed | -$1K | – | 3917 |
|
|
2016
Q2 | $1K | Buy |
50
+33
| +194% | +$660 | ﹤0.01% | 3363 |
|
|
2016
Q1 | $1K | Sell |
17
-24
| -59% | -$1.41K | ﹤0.01% | 3271 |
|
|
2015
Q4 | $2K | Sell |
41
-712
| -95% | -$34.7K | ﹤0.01% | 3018 |
|
|
2015
Q3 | $60K | Sell |
753
-36
| -5% | -$2.87K | ﹤0.01% | 2534 |
|
|
2015
Q2 | $126K | Sell |
789
-1,163
| -60% | -$186K | ﹤0.01% | 2262 |
|
|
2015
Q1 | $781K | Buy |
1,952
+1,903
| +3,884% | +$761K | ﹤0.01% | 1709 |
|
|
2014
Q4 | $26K | Buy |
+49
| New | +$26K | ﹤0.01% | 3316 |
|